Document is current
Any future updates will be listed below
-
Authors
Monte, Gabriele https://orcid.org/0000-0002-4763-7784
Tiralongo, Giuseppe
Papetti, Laura
Ferilli, Michela Ada Noris
Proietti Checchi, Martina
Voci, Alessandra
Ruscitto, Claudia
Salvetti, Marco
Bellucci, Gianmarco
Valeriani, Massimiliano
-
Funding
Funding for this research was provided by:
Ministero della Salute
- License Information
-
More Information
Article History
Received: 21 July 2025
Revised: 7 October 2025
Accepted: 11 October 2025
First Online: 29 October 2025
Declarations
:
: GM, GT, GB, LP, MANF, MPC, AV, CR, MV: nothing to disclose. MS: speaking honoraria from Biogen, BMS, Horizon, Merck, Novartis, Roche, Sanofi, Viatris, Patent on EBNA2 alleles in multiple sclerosis (IT1417523 EP2981625).
: The study was approved by the Bambino Gesù Children’s Hospital Institutional Review Board and was performed in accordance with the Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all subjects involved in the study.
